- Home
- WATT vs SHPH Comparison
WATT vs SHPH Comparison
Compare WATT & SHPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WATT
- SHPH
- Stock Information
- Founded
- WATT 2012
- SHPH 2012
- Country
- WATT United States
- SHPH United States
- Employees
- WATT N/A
- SHPH N/A
- Industry
- WATT Radio And Television Broadcasting And Communications Equipment
- SHPH Biotechnology: Pharmaceutical Preparations
- Sector
- WATT Technology
- SHPH Health Care
- Exchange
- WATT Nasdaq
- SHPH Nasdaq
- Market Cap
- WATT 3.9M
- SHPH 3.3M
- IPO Year
- WATT 2014
- SHPH 2022
- Fundamental
- Price
- WATT $0.61
- SHPH $1.41
- Analyst Decision
- WATT Strong Buy
- SHPH
- Analyst Count
- WATT 2
- SHPH 0
- Target Price
- WATT $2.25
- SHPH N/A
- AVG Volume (30 Days)
- WATT 133.2K
- SHPH 43.1K
- Earning Date
- WATT 11-07-2024
- SHPH 11-12-2024
- Dividend Yield
- WATT N/A
- SHPH N/A
- EPS Growth
- WATT N/A
- SHPH N/A
- EPS
- WATT N/A
- SHPH N/A
- Revenue
- WATT $370,184.00
- SHPH N/A
- Revenue This Year
- WATT $95.75
- SHPH N/A
- Revenue Next Year
- WATT $834.07
- SHPH N/A
- P/E Ratio
- WATT N/A
- SHPH N/A
- Revenue Growth
- WATT N/A
- SHPH N/A
- 52 Week Low
- WATT $0.54
- SHPH $1.03
- 52 Week High
- WATT $2.75
- SHPH $4.94
- Technical
- Relative Strength Index (RSI)
- WATT 48.13
- SHPH 49.84
- Support Level
- WATT $0.56
- SHPH $1.12
- Resistance Level
- WATT $0.61
- SHPH $1.26
- Average True Range (ATR)
- WATT 0.04
- SHPH 0.11
- MACD
- WATT 0.01
- SHPH 0.06
- Stochastic Oscillator
- WATT 69.60
- SHPH 68.09
About WATT Energous Corporation
Energous Corp has developed wireless power networks technology (WPNT), consisting of semiconductor chipsets, software controls, hardware designs and antennas, that enable radio frequency (RF) based charging for Internet of Things (IoT) devices. Its products include Transmitter IC & Module, Receivers IC, Transmitter System and other tools.
About SHPH Shuttle Pharmaceuticals Holdings Inc.
Shuttle Pharmaceuticals Holdings Inc is a clinical stage pharmaceutical company leveraging our proprietary technology to develop novel therapies designed to cure cancers. The company's goal is to extend the benefits of cancer treatments by leveraging insights into the pillars of cancer therapy: surgery, radiation therapy, chemotherapy, and immunotherapy.